SC

SciBase Holding AB (publ)FNSE SciBase Holding Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Oct, 2024

Last price

Market cap $B

0.009

Micro

Exchange

FNSE - First North Sweden

SCIB.ST Stock Analysis

SC

Uncovered

SciBase Holding AB (publ) is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

36/100

Low score

Market cap $B

0.009

Dividend yield

Shares outstanding

119.83 B

Website

SciBase Holding AB is a global medical technology company, which engages in the development and sale of instruments for the detection of skin cancer and other skin diseases. The company is headquartered in Sundbyberg, Stockholm. The company went IPO on 2015-06-02. The firm specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. The diagnostic product is sold in Nordic countries, Belgium, Germany, Great Britain and Australia.

View Section: Eyestock Rating